AXHE iShares MSCI ACWI ex U.S. Healthcare ETF
- Health & Biotech Equities
AXHE - Profile
- Issuer: iShares
- Structure: ETF
- Expense Ratio: 0.48%
- ETF Home Page: AXHE
- Inception: Jul 13, 2010
- Tax Form: 1099
- AXHE Tracks This Index: MSCI All Country World ex USA Health Care Index
- 52 Week Lo: $68.52
- 52 Week Hi: $87.90
- AUM: $12.6 M
- Shares: 0.2 M
Alternative ETFs in the Health & Biotech Equities Category
|Type||Ticker||Expense Ratio||Assets||Avg. Daily Vol||YTD Return|
|Most Liquid (Volume)|
|Top YTD Performer|
The index is a free-float adjusted market capitalization weighted index designed to measure the combined equity market performance of the health care sector of developed and emerging markets countries, excluding the U.S.
AXHE - Realtime Rating
Realtime Rating Summary
AXHE is a passive ETF that seeks to replicate MSCI All Country World ex USA Health Care Index. The index is a free-float adjusted market capitalization weighted index designed to measure the combined equity market performance of the health care sector of developed and emerging markets countries, excluding the U.S.
The adjacent table gives investors an individual Realtime Rating for AXHE on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
AXHE In-Depth Analysis
The following tables and charts contain in-depth metrics for AXHE and compare it to similar peer ETFs within its ETFdb Category.
AXHE - HoldingsFilings Data as of: Mar 04, 2014
Top Ten Holdings
RHHVF 13.94%Roche Holding AG
NVSEF 12.16%Novartis AG
GLAXF 8.65%GlaxoSmithKline PLC
NONOF 5.47%Novo Nordisk A/S
AZNCF 5.44%AstraZeneca PLC
BAYN 4.69%Bayer AG
VRX 3.21%Valeant Pharmaceuticals International Inc
TEVJF 2.76%Teva Pharmaceutical Industries Ltd
TKPHF 2.42%Takeda Pharmaceutical Co., Ltd.
This section compares how balanced and deep AXHE is relative to the peer group ETFdb Category.
AXHE Asset Allocation
AXHE Sector Breakdown
AXHE Market Cap Breakdown
AXHE Region Breakdown
AXHE Market Tier Breakdown
AXHE Country Breakdown
AXHE - Expenses & Fees
This section compares the cost efficiency of AXHE to peers in the same ETFdb Category.
Expenses Ratio Analysis
Commission Free Trading in AXHE
AXHE is not currently available for commission free trading on any platforms.
Category Commission Free Trading
There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:
AXHE - Performance
This section shows how AXHE has performed relative to its peer group ETFdb Category.
AXHE - Technicals
AXHE Volatility Analysis
This section shows how the volatility of AXHE compares to the peer group ETFdb Category.
- 20 Day MA: $86.25
- 60 Day MA: $83.32
- MACD 15 Period: -1.56
- MACD 100 Period: 3.29
- Williams % Range 10 Day: 72.18
- Williams % Range 20 Day: 74.62
- RSI 10 Day: 44
- RSI 20 Day: 50
- RSI 30 Day: 52
- Ultimate Oscillator: 34
AXHE Bollinger Bands
- Lower Bollinger (10 Day): $83.51
- Upper Bollinger (10 Day): $88.18
- Lower Bollinger (20 Day): $84.31
- Upper Bollinger (20 Day): $88.29
- Lower Bollinger (30 Day): $81.69
- Upper Bollinger (30 Day): $89.25
AXHE Support & Resistance
- Support Level 1: n/a
- Support Level 2: $82.78
- Resistance Level 1: n/a
- Resistance Level 2: $85.60
- Stochastic Oscillator %D (1 Day): 46.17
- Stochastic Oscillator %D (5 Day): 22.95
- Stochastic Oscillator %K (1 Day): 41.83
- Stochastic Oscillator %K (5 Day): 29.87
Latest AXHE News
ETFs & Sector Rotation: Large Cap, Small Cap, Or International?
May ETFdb Category Kings: Best Performing ETFs
July ETF Roundup: Launches and Filings
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.